New Policy Directions for Biomedical Innovation
On November 19, the Engelberg Center for Health Care Reform at Brookings hosted an event examining the outlook and opportunities for biomedical innovation in a challenging fiscal environment. Leaders in the field offered their thoughts on future directions of and policy priorities for the innovation enterprise. Following a brief keynote, a panel of senior thought leaders provided further discussion on actionable next steps to improve biomedical innovation.
Director, National Center for Advancing Translational Sciences - National Institutes of Health
Co-Founder and Executive Vice Chairman - The Michael J. Fox Foundation
Regulatory Leader and Distinguished Lilly Scholar - Eli Lilly and Company
Professor, Department of Experimental Therapeutics, Division of Cancer Medicine and Director, Khalifa Institute for Personalized Cancer Therapy - The University of Texas MD Anderson Cancer Center
Executive Vice President of Innovation & Dissemination - Geisinger Health Solutions
To subscribe or manage your subscriptions to our top event topic lists, please visit our event topics page.